Regulation of uridine kinase activity in BALB/C-3T3 cells by serum components.
After the stimulation of quiescent density-inhibited BALB/c-3T3 cells with fresh bovine calf serum, uridine kinase activity measured in cellular extracts increased between hours 3 and 6 of incubation and remained elevated through 12 h after stimulation. The addition of either partially purified platelet-derived growth factor (PDGF) or platelet-poor plasma (PPP) also caused increased uridine kinase activity by 6 h, but the increased activity was not maintained and the activity returned to the prestimulated level by 12 h. However, when PDGF and PPP were added in combination an increased level of uridine kinase activity was maintained in a manner similar to that seen after the addition of serum. The components of PPP eluted in the void volume from Sephadex G-50 chromatography did not induce uridine kinase activity when present alone, although they did act synergistically with PDGF to allow the maintenance of elevated levels or uridine kinase activity over the period from 6 to 12 h after stimulation. Thymidine kinase activity was not induced by the addition of either PDGF or PPP alone, although either serum or the combination of PDGF and PPP did produce and induction of thymidine kinase activity in late G1.
D000818:Animals; D001792:Blood Platelets; D002453:Cell Cycle; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis; D004790:Enzyme Induction / Q000187:drug effects; D006133:Growth Substances / Q000097:blood / Q000494:pharmacology; D051379:Mice; D008934:Mitogens / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D010770:Phosphotransferases / Q000378:metabolism*; D010982:Platelet-Derived Growth Factor; D013937:Thymidine Kinase / Q000096:biosynthesis; D014541:Uridine Kinase / Q000378:metabolism*
D006133:Growth Substances; D008934:Mitogens; D010455:Peptides; D010982:Platelet-Derived Growth Factor; D004247:DNA; D010770:Phosphotransferases; D013937:Thymidine Kinase; D014541:Uridine Kinase